{
  "data": {
    "indicator": {
      "slug": "patient-organization-input-share-in-drug-health-technology-assessments",
      "name": "Patient organization input share in drug health technology assessments",
      "definition": "Share of drug health technology assessments that receive formal input from patient organizations.",
      "unit": "percent",
      "scale": "1",
      "default_unit": "percent",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "percent",
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "points": [
      {
        "period_start": "2023-01-01",
        "period_label": "as of 5 Oct 2023",
        "value": 21,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_2PDYD6WDHANXDRA4GCD6QEQ700",
        "url": "https://statorigin.org/stat/stat_2PDYD6WDHANXDRA4GCD6QEQ700",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Supporting patients through research collaboration",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration",
          "locator": "Patient organizations now provide input into 21% of all drug health technology assessments (HTAs) globally and up to 52% in some therapy areas in EU and Commonwealth countries.",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "GLOBAL",
      "EU"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}